Return to homepagePandemic Pact

Study of the role of clonal hematopoiesis as a factor of susceptibility to infection by COVID19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    ANR

  • Principal Investigator

    Zlad MALLAT

  • Research Location

    France

  • Lead Research Institution

    Paris Centre de Recherche Cardiovasculaire / Hôpital européen Georges-Pompidou

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The CHIP-COVID-19 project, coordinated by Ziad Mallat (Paris Cardiovascular Research Center / European Hospital Georges-Pompidou), focuses on the study of the role of clonal hematopoiesis as a factor of susceptibility to infection by COVID-19 . Many people have abnormal blood cells in their bodies due to random genetic changes that occur over time. These cells react abnormally to inflammation, which leads to many diseases. Researchers want to test whether these cells are responsible for serious COVID-19 disease.